Open Access
Open access
volume 13 issue 1 pages 102-119

Acute and Post-Acute Neurological Complications of COVID-19

Ali Al Ramadan 1, 2
Omar Rababh 1, 2
Jawad Shah 1, 2, 3, 4, 5
Abeer Gharaibeh 1, 2, 3, 5
1
 
Insight Research Institute, Flint, MI 48507, USA
3
 
Insight Research Center, Insight Institute of Neurosurgery & Neuroscience, Flint, MI 48507, USA
5
 
Insight Surgical Hospital, Warren, MI 48091, USA
Publication typeJournal Article
Publication date2021-03-09
scimago Q2
wos Q2
SJR1.021
CiteScore4.8
Impact factor3.0
ISSN20358385, 20358377
Neurology (clinical)
Abstract

Coronavirus disease 2019 (COVID-19) is an emerging global health emergency caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The global outbreak of SARS-CoV-2 infection has been declared a global pandemic by the World Health Organization (WHO). The clinical presentation of SARS-CoV-2 infection depends on the severity of the disease and may range from an asymptomatic infection to a severe and lethal illness. Fever, cough, and shortness of breath are among the most common symptoms associated with SARS-CoV-2 infection. Accumulating evidence indicates that COVID-19 patients commonly develop neurological symptoms, such as headache, altered mental status, anosmia, and myalgia. In this comprehensive literature review, we have summarized the most common neurological complications and reported neurological case studies associated with COVID-19, and neurological side effects associated with COVID-19 treatments. Additionally, the post-acute COVID-19 syndrome and long-term neurological complications were discussed. We also explained the proposed mechanisms that are involved in the pathogenesis of these neurological complications.

Found 
Found 

Top-30

Journals

1
2
3
4
Brain Sciences
4 publications, 5.13%
Frontiers in Neurology
4 publications, 5.13%
Journal of Clinical Medicine
2 publications, 2.56%
Molecular Medicine
2 publications, 2.56%
Annals of Medicine and Surgery
2 publications, 2.56%
PLoS ONE
2 publications, 2.56%
Cureus
2 publications, 2.56%
Current Topics in Medicinal Chemistry
1 publication, 1.28%
Journal of Alzheimer's Disease
1 publication, 1.28%
Pain Reports
1 publication, 1.28%
SAGE Open Medical Case Reports
1 publication, 1.28%
Journal of Personalized Medicine
1 publication, 1.28%
Pathogens
1 publication, 1.28%
Molecules
1 publication, 1.28%
Medicina
1 publication, 1.28%
Frontiers in Pediatrics
1 publication, 1.28%
Frontiers in Aging Neuroscience
1 publication, 1.28%
Children
1 publication, 1.28%
Egyptian Journal of Neurology, Psychiatry and Neurosurgery
1 publication, 1.28%
Journal of Thrombosis and Thrombolysis
1 publication, 1.28%
Neuroscience and Behavioral Physiology
1 publication, 1.28%
eLife
1 publication, 1.28%
Journal of the American Dental Association
1 publication, 1.28%
Heliyon
1 publication, 1.28%
Semergen
1 publication, 1.28%
Autoimmunity Reviews
1 publication, 1.28%
European Journal of Cancer
1 publication, 1.28%
Journal of Neuroimmunology
1 publication, 1.28%
Revista Colombiana de Reumatologia
1 publication, 1.28%
1
2
3
4

Publishers

2
4
6
8
10
12
14
16
18
Elsevier
18 publications, 23.08%
MDPI
14 publications, 17.95%
Springer Nature
11 publications, 14.1%
Frontiers Media S.A.
7 publications, 8.97%
Bentham Science Publishers Ltd.
3 publications, 3.85%
SAGE
3 publications, 3.85%
Ovid Technologies (Wolters Kluwer Health)
3 publications, 3.85%
Wiley
3 publications, 3.85%
Public Library of Science (PLoS)
2 publications, 2.56%
Media Sphere Publishing House
2 publications, 2.56%
Hindawi Limited
2 publications, 2.56%
Medknow
2 publications, 2.56%
eLife Sciences Publications
1 publication, 1.28%
Asociacion Colombiana de Reumatologia
1 publication, 1.28%
Taylor & Francis
1 publication, 1.28%
Eco-Vector LLC
1 publication, 1.28%
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology
1 publication, 1.28%
Research Square Platform LLC
1 publication, 1.28%
Alfmed LLC
1 publication, 1.28%
Spandidos Publications
1 publication, 1.28%
2
4
6
8
10
12
14
16
18
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
78
Share
Cite this
GOST |
Cite this
GOST Copy
Al Ramadan A. et al. Acute and Post-Acute Neurological Complications of COVID-19 // Neurology International. 2021. Vol. 13. No. 1. pp. 102-119.
GOST all authors (up to 50) Copy
Al Ramadan A., Rababh O., Shah J., Gharaibeh A. Acute and Post-Acute Neurological Complications of COVID-19 // Neurology International. 2021. Vol. 13. No. 1. pp. 102-119.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/neurolint13010010
UR - https://doi.org/10.3390/neurolint13010010
TI - Acute and Post-Acute Neurological Complications of COVID-19
T2 - Neurology International
AU - Al Ramadan, Ali
AU - Rababh, Omar
AU - Shah, Jawad
AU - Gharaibeh, Abeer
PY - 2021
DA - 2021/03/09
PB - MDPI
SP - 102-119
IS - 1
VL - 13
PMID - 33803475
SN - 2035-8385
SN - 2035-8377
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Al Ramadan,
author = {Ali Al Ramadan and Omar Rababh and Jawad Shah and Abeer Gharaibeh},
title = {Acute and Post-Acute Neurological Complications of COVID-19},
journal = {Neurology International},
year = {2021},
volume = {13},
publisher = {MDPI},
month = {mar},
url = {https://doi.org/10.3390/neurolint13010010},
number = {1},
pages = {102--119},
doi = {10.3390/neurolint13010010}
}
MLA
Cite this
MLA Copy
Al Ramadan, Ali, et al. “Acute and Post-Acute Neurological Complications of COVID-19.” Neurology International, vol. 13, no. 1, Mar. 2021, pp. 102-119. https://doi.org/10.3390/neurolint13010010.